Litcius/Paper detail

Evaluation of Pharmacokinetic Interactions Between the New SGLT2 Inhibitor SHR3824 and Valsartan in Healthy Chinese Volunteers

Yunzhe Huang, Ran Liu, Yaqin Wang, Gege Liu, Changmao Wang, Xinyan Chen, Yuanwei Jia, Jie Shen

2022Clinical Therapeutics14 citationsDOI

Topics & Concepts

PharmacokineticsValsartanMedicineCmaxPharmacologyInternal medicineBlood pressureDiabetes Treatment and ManagementBlood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes
Evaluation of Pharmacokinetic Interactions Between the New SGLT2 Inhibitor SHR3824 and Valsartan in Healthy Chinese Volunteers | Litcius